*/
Marie Law, Director of Toxicology at AlphaBiolabs, examines the most recent data on alcohol misuse in the UK, and the implications for alcohol testing in family proceedings
Alcohol misuse remains a persistent and growing concern across the UK. According to the Office for National Statistics (ONS), 10,473 alcohol-specific deaths were registered in the UK in 2023, the highest number on record.
And data from the Children’s Commissioner for England indicates that 478,000 children were living with an alcohol- or drug-dependent parent in 2019–20.
Where parental alcohol misuse is alleged or suspected, objective, court-admissible evidence is essential, and the testing options available are broader than many practitioners may realise.
Alcohol misuse does not always present in ways that are immediately apparent. Functional dependency – where a person maintains daily responsibilities while consuming harmful levels of alcohol – can be difficult to identify through observation or self-disclosure alone.
Symptoms can also overlap with those of other conditions, including mental health disorders and prescription medication use, making clinical assessment alone an unreliable evidential basis for court proceedings, and reinforcing the value of scientifically robust, court-admissible laboratory testing in building an accurate evidential picture.
No single test provides a complete picture of an individual’s alcohol use. The most effective strategies combine narrow-window and wide-window methods, selected according to the timeframe under consideration and the evidential requirements of the case.
Breath testing: Provides an immediate indication of current alcohol consumption. Best suited to confirming sobriety in real time – for example, prior to or during a contact session. Detection window: real-time.
Blood testing (PEth, CDT, LFT & MCV): Blood testing encompasses both direct and indirect markers of alcohol consumption.
Phosphatidylethanol (PEth) is a direct biomarker, meaning it can only be elevated as a result of drinking. Available via finger prick or venepuncture, it can detect consumption across a range of levels, from abstinence and social drinking through to chronic and excessive use, making it the gold standard for ongoing monitoring.
Carbohydrate Deficient Transferrin (CDT), Mean Corpuscular Volume (MCV) and Liver Function Tests (LFT) are indirect markers, each with differing detection windows. All three can be elevated by medical conditions unrelated to alcohol use, and should be considered alongside other evidence when interpreting results.
Detection windows: PEth, up to 4 weeks; CDT, up to 1 month; MCV, approximately 4 months; LFT, snapshot in time.
Hair alcohol testing: Testing head hair for the biomarkers Ethyl Glucuronide (EtG) and Ethyl Palmitate (EtPA) provides one of the widest detection windows available. Samples can be analysed as an overview across the full period, or segmented month by month, enabling the court to identify patterns such as escalating use, periods of abstinence, or relapse. Detection window: up to 12 months
Nail alcohol testing: Where head hair is unavailable, EtG testing using nail clippings offers a comparable alternative. Fingernail or toenail clippings can be collected but offer differing detection windows as they grow at different rates. Detection windows: Fingernail clippings, up to 6-month overview; Toenail clippings, up to 12-month overview.
SCRAM CAM®: The SCRAM ankle bracelet provides real-time, continuous monitoring by taking transdermal readings through the skin every 30 minutes. Particularly appropriate where a parent must demonstrate sustained compliance with a court order or abstinence condition. Detection window: continuous, for as long as the device is worn.
Selecting the most appropriate testing method, and ensuring results are expertly interpreted, is essential to supporting robust, evidence-led decisions in the best interests of vulnerable children and families.
AlphaBiolabs is a UKAS 17025-accredited laboratory (including Lab 51 extension for toxicology) with over 20 years’ experience supporting family law professionals, social workers and local authorities with court-admissible alcohol testing, including bespoke testing schedules for repeat or ongoing monitoring cases.
Alcohol misuse remains a persistent and growing concern across the UK. According to the Office for National Statistics (ONS), 10,473 alcohol-specific deaths were registered in the UK in 2023, the highest number on record.
And data from the Children’s Commissioner for England indicates that 478,000 children were living with an alcohol- or drug-dependent parent in 2019–20.
Where parental alcohol misuse is alleged or suspected, objective, court-admissible evidence is essential, and the testing options available are broader than many practitioners may realise.
Alcohol misuse does not always present in ways that are immediately apparent. Functional dependency – where a person maintains daily responsibilities while consuming harmful levels of alcohol – can be difficult to identify through observation or self-disclosure alone.
Symptoms can also overlap with those of other conditions, including mental health disorders and prescription medication use, making clinical assessment alone an unreliable evidential basis for court proceedings, and reinforcing the value of scientifically robust, court-admissible laboratory testing in building an accurate evidential picture.
No single test provides a complete picture of an individual’s alcohol use. The most effective strategies combine narrow-window and wide-window methods, selected according to the timeframe under consideration and the evidential requirements of the case.
Breath testing: Provides an immediate indication of current alcohol consumption. Best suited to confirming sobriety in real time – for example, prior to or during a contact session. Detection window: real-time.
Blood testing (PEth, CDT, LFT & MCV): Blood testing encompasses both direct and indirect markers of alcohol consumption.
Phosphatidylethanol (PEth) is a direct biomarker, meaning it can only be elevated as a result of drinking. Available via finger prick or venepuncture, it can detect consumption across a range of levels, from abstinence and social drinking through to chronic and excessive use, making it the gold standard for ongoing monitoring.
Carbohydrate Deficient Transferrin (CDT), Mean Corpuscular Volume (MCV) and Liver Function Tests (LFT) are indirect markers, each with differing detection windows. All three can be elevated by medical conditions unrelated to alcohol use, and should be considered alongside other evidence when interpreting results.
Detection windows: PEth, up to 4 weeks; CDT, up to 1 month; MCV, approximately 4 months; LFT, snapshot in time.
Hair alcohol testing: Testing head hair for the biomarkers Ethyl Glucuronide (EtG) and Ethyl Palmitate (EtPA) provides one of the widest detection windows available. Samples can be analysed as an overview across the full period, or segmented month by month, enabling the court to identify patterns such as escalating use, periods of abstinence, or relapse. Detection window: up to 12 months
Nail alcohol testing: Where head hair is unavailable, EtG testing using nail clippings offers a comparable alternative. Fingernail or toenail clippings can be collected but offer differing detection windows as they grow at different rates. Detection windows: Fingernail clippings, up to 6-month overview; Toenail clippings, up to 12-month overview.
SCRAM CAM®: The SCRAM ankle bracelet provides real-time, continuous monitoring by taking transdermal readings through the skin every 30 minutes. Particularly appropriate where a parent must demonstrate sustained compliance with a court order or abstinence condition. Detection window: continuous, for as long as the device is worn.
Selecting the most appropriate testing method, and ensuring results are expertly interpreted, is essential to supporting robust, evidence-led decisions in the best interests of vulnerable children and families.
AlphaBiolabs is a UKAS 17025-accredited laboratory (including Lab 51 extension for toxicology) with over 20 years’ experience supporting family law professionals, social workers and local authorities with court-admissible alcohol testing, including bespoke testing schedules for repeat or ongoing monitoring cases.
Marie Law, Director of Toxicology at AlphaBiolabs, examines the most recent data on alcohol misuse in the UK, and the implications for alcohol testing in family proceedings
The Chair of the Bar reports back
Clement Cowley, Partner at The Penny Group, explains how global events can influence the performance of pensions and ISAs, and why taking a long-term approach to investing is often the most effective strategy
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, discusses what family law professionals need to know about hallucinogens, from the main hallucinogenic drugs encountered in family proceedings, to their effects and the testing options available
Harmony Christian Ministries is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
At the start of her term, Chair of the Bar 2026 Kirsty Brimelow KC set out a series of priorities for the year ahead. One of those priorities was children in the justice system
Reviewed by Daniel Barnett
James McNeill Whistler at Tate Britain until 27 September Rothko in Florence at Palazzo Strozzi until 23 August Reviewed by Stephen Cragg KC
The Chief Legal Officer to the Metropolitan Police, barrister Brett Welch, tells Anthony Inglese CB about his mission and the work to turn the Met around
Barrister apprenticeships – shortly to provide the fourth pathway to the Bar – are an ideal opportunity to support local talent and ‘grow your own’, say Tim Coulson and Dr Jane Dennehy
